Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	ZA6965	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Y255*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP			NA	NA	NA	3	138664800	138664800	G	C	3:g.138664800G>C	ENST00000330315.3:c.765C>G	0.20		2	8		16	220	1/1					3	57	Pembrolizumab (Dose 2 mg/kg)	Not reached 6 months follow-up	Censored	0.9515	Adenocarcinoma	Transversion High	111	223	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	4.4	1	1	Female	Former	25	Matched	7.33333333333	342	PR																																																	
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004802-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G269Afs*2	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	3	138664761	138664761	G	-	3:g.138664761del	ENST00000330315.3:c.804del							13	1/1	0.000083439	Pathogenic				68				0.0523						LUAD				1	Female	Former heavy		Matched	12.723356069			NO	KRAS	IMPACT410	NO	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	934	NO	Metastasis		IV	NO	YES		DOD																													
Lung Adenocarcinoma (MSKCC, Science 2015)	RI1933	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Y57N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.991	Missense_Mutation	SNP			NA	NA	NA	3	138665396	138665396	A	T	3:g.138665396A>T	ENST00000330315.3:c.169T>A	0.20		25	102		52	468	1/1		Likely_pathogenic	rs1559922647		3	60	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.8744	Adenocarcinoma	Transversion High	228	473	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	16.6	1	1	Female	Former	21	Matched	15.6	622	PR																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0003119-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G119C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	3	138665210	138665210	C	A	3:g.138665210C>A	ENST00000330315.3:c.355G>T	0.09		99	945		321	13	1/1						53		NO		0.0994						LUAD		5.57		1	Male			Matched	12.723356069					IMPACT410																							1:Progressed																	0.1	Commercial	5	12.26415094		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0002639-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R145L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.997	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	3	138665131	138665131	C	A	3:g.138665131C>A	ENST00000330315.3:c.434G>T	0.10		47	419		149	11	1/1						67		YES		0.0357						LUAD		8.1		1	Female			Matched	12.2007083066					IMPACT341																							0:Not Progressed																	0.04	Commercial	2	11.2244898		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G240S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.99;Polyphen-2: impact: benign, score: 0.344	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	3	138664847	138664847	C	T	3:g.138664847C>T	ENST00000330315.3:c.718G>A	0.60		45	30		22	90	1/1	0.0002444748679835713		rs767088367	0.00012		53		YES		0.5235						LUAD		13.17		1	Male			Matched	96.496511152					IMPACT341																							1:Progressed																	0.52	Commercial	2	91.83673469		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0011192-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A229T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.5;Polyphen-2: impact: benign, score: 0.215	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	3	138664880	138664880	C	T	3:g.138664880C>T	ENST00000330315.3:c.685G>A	0.05		10	180		36	11	1/1	0.000016922764502809178		rs757038357			74		NO		0.0292						LUAD		2.27		1	Female			Matched	10.7659166738					IMPACT410																							1:Progressed																	0.03	Commercial	2	10.37735849		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0011244-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	G269C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious_low_confidence, score: 0;Polyphen-2: impact: probably_damaging, score: 0.914	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	3	138664760	138664760	C	A	3:g.138664760C>A	ENST00000330315.3:c.805G>T	0.07		27	381		137	3	1/1						76		NO		0.0017						LUSC		2.1		1	Male			Matched	2.93615909284					IMPACT410																							1:Progressed																	0	Commercial	2	2.830188679		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s66	Lung cancer	Lung Adenocarcinoma	P157A	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.14;Polyphen-2: impact: benign, score: 0.007	Missense_Mutation	SNP			NA	NA	MSKCC	3	138665096	138665096	G	C	3:g.138665096G>C	ENST00000330315.3:c.469C>G	0.27		43	119			219	1/1	0.00000490692		rs758370933					No Durable Benefit			Squamous			192		LUAD		0.0329		1	Male			Matched	7.33333333333																												0:Censor					76	NE	1	A*02:01	A*24:02	B*18:01	B*35:02	C*07:01	C*04:01	0.0	425	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s51	Lung cancer	Lung Adenocarcinoma	P6H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.31;Polyphen-2: impact: benign, score: 0.007	Missense_Mutation	SNP			NA	NA	MSKCC	3	138665548	138665548	G	T	3:g.138665548G>T	ENST00000330315.3:c.17C>A	0.52		59	55			1381	1/1								Durable Clinical Benefit			Non-Squamous			1175		LUAD		29.9302		1	Female			Matched	46.0666666667																												0:Censor					56	PR	1	A*02:01	A*11:01	B*45:01	B*18:01	C*07:01	C*06:02	0.0	3170	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003119-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G119C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138665210	138665210	C	A	3:g.138665210C>A	ENST00000330315.3:c.355G>T							13	1/1						51				0.0994						LUAD				1	Male	Former heavy		Matched	12.723356069			NO	MET_AMP	IMPACT410	YES	MSKCC	2		Adenocarcinoma	Lung	YES	Tumor	951	NO	Primary	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009223-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A283S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.11;Polyphen-2: impact: possibly_damaging, score: 0.84	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138664718	138664718	C	A	3:g.138664718C>A	ENST00000330315.3:c.847G>T							37	1/1						68				0.0853						LUAD				1	Male	Former heavy		Matched	36.2126288117			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	881	YES	Metastasis		IV	NO	YES	10	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002611-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	H291N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.1;Polyphen-2: impact: benign, score: 0.069	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138664694	138664694	G	T	3:g.138664694G>T	ENST00000330315.3:c.871C>A							57	1/1						50				0.0369						LUAD				1	Female	Former heavy		Matched	63.2218521341			NO	UNKNOWN DRIVER	IMPACT341	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	464	YES	Metastasis		IIIB	NO	YES		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002611-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S107R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.993	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138665244	138665244	G	C	3:g.138665244G>C	ENST00000330315.3:c.321C>G							57	1/1						50				0.0369						LUAD				1	Female	Former heavy		Matched	63.2218521341			NO	UNKNOWN DRIVER	IMPACT341	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	464	YES	Metastasis		IIIB	NO	YES		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002639-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R145L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.997	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	3	138665131	138665131	C	A	3:g.138665131C>A	ENST00000330315.3:c.434G>T							11	1/1						65				0.0357						LUAD				1	Female	Former heavy		Matched	12.2007083066			NO	UNKNOWN DRIVER	IMPACT341	YES	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	760	YES	Primary	Note: The TP53 exon5 mutations all occur in cis on the same allele.	IA	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G240S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated_low_confidence, score: 0.99;Polyphen-2: impact: benign, score: 0.344	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138664847	138664847	C	T	3:g.138664847C>T	ENST00000330315.3:c.718G>A							90	1/1	0.0002444748679835713		rs767088367	0.00012		51				0.5235						LUAD				1	Male	Former heavy		Matched	96.496511152			YES	PIK3CA	IMPACT341	YES	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	1189	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008261-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A249E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious_low_confidence, score: 0.01;Polyphen-2: impact: benign, score: 0.134	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	3	138664819	138664819	G	T	3:g.138664819G>T	ENST00000330315.3:c.746C>A							11	1/1						58				0.5027						LUAD				1	Female	Former heavy		Matched	10.7659166738			NO	KRAS	IMPACT410	NO	MSKCC	0	Brain	Adenocarcinoma	Lung	YES	Tumor	837	YES	Metastasis	Note: Copy number profile is suggestive of broad copy number amplification on Chromosome arms 17q22-24.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 9p21-24.	IV	NO	NO	90	AWD																													
Non-small cell lung cancer (MSK, Science 2015)	RI1933	Lung cancer	Lung Adenocarcinoma	Y57N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.991	Missense_Mutation	SNP			Somatic	NA	MSKCC	3	138665396	138665396	A	T	3:g.138665396A>T	ENST00000330315.3:c.169T>A							468	1/1		Likely_pathogenic	rs1559922647					DCB			Adenocarcinoma	Transversion High	228	473		LUAD	Strong	16.6	1	1	Female	Former		Matched	15.5333333333	622												Tumor			Met							60	10	68.188206	164.985052	Partial Response	0:Censure	FFPE	21.0	Lymph node	3																			
